During the last five or six years, Indian pharmaceutical industry has made its global presence felt and that too mainly in North America and Europe, two major pharmaceutical markets. This is just the beginning of a new phase for the Indian pharmaceutical industry and export is going to be the mainstay of this sector in the years to come. The focus of export is mainly in value added generic business and not in APIs as was the case in the eighties. And it will not be the monopoly of only a dozen top pharmaceutical companies of the country any more. Export or perish is going to be a slogan in this industry in the years to come. No wonder, a large number of India's medium and small pharmaceutical companies are looking seriously at the export business today. For this, pharmaceutical companies have to remain internationally competitive by having regular exposures to these markets. The developed markets of the US and Europe demand the best of pharmaceutical products using latest technologies and materials. India's large pharmaceutical companies with their financial muscle are already familiar with the international market and advanced technologies available for making their products acceptable globally. But the medium and small scale players are not. They need constant interaction with potential buyers, suppliers of packaging materials and ever changing technologies. Trade shows and exhibitions play a key role in this familiarization process and business development especially for smaller players. The main international show known to Indian pharmaceutical industry until recently was CPhI which is more considered as an event for API producers. India being a global generic player today, it has to seriously look at its formulation manufacturing practices and has to constantly upgrade these standards. For this, Indian pharmaceutical industry needs to focus on advanced formulation technologies, sophisticated production machineries and latest packaging solutions to remain competitive in the export markets. Interphex show run by Reed Life Sciences, a part of Reed Exhibitions, provides, probably, the best forum for pharmaceutical companies and the allied sector industry of India for this interaction. The annual event is rated as the show that covers many facets of drug and biopharmaceutical manufacturing process. Broadly it covers segments like Pharma Facilities, Pharma Sourcing & Services, Pharma IT and Pharma Manufacturing. World's top ten pharmaceutical corporations starting from Pfizer and GSK, ten leading global biopharmaceutical companies and many major generic companies participate in Interphex, USA every year. The latest Interphex 2007 at New York in April last attracted 1200 companies from 40 countries. The wide acceptance of the event convinced Reed Exhibitions to take Interphex outside the US to countries such as UK, Japan, Singapore, China, Mexico, Puerto Rico and now to India. The decision to bring the show to India is in response to demand by a large number of international and Indian pharmaceutical companies. The India show planned in September this year should provide a major opportunity for a large number of Indian companies and allied sector units who are unable to participate in Interphex US.